biomea fusion
Yuko Kosaka is a clinical biosample senior manager at Biomea Fusion, with extensive experience in the biosciences sector. Yuko's previous roles include statistician and data science at Cognoa, associate scientist positions at PTC Therapeutics, and multiple research associate roles at Edison Pharmaceuticals, now BioElectron Technology Corporation. Earlier experience includes positions at Novartis Institutes for BioMedical Research and 3-V Biosciences, as well as an assistant research scientist role at Exelixis. Yuko holds a Master of Science in Statistics from Texas A&M University and a Bachelor of Science in Nutritional Science from the University of California, Berkeley.
biomea fusion
Biomea Fusion, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of irreversible small molecules to treat patients with genetically defined cancers. The company was formed in 2017 by a small group of biotech executives that came together with the common goal of achieving better therapies for patients.